Clinical Trials Logo
  1. Home
  2. Coagulopathy
  3. NCT04507230
  4. Details
NCT04507230 Clinical Trial

COVID-19 Associated Coagulopathy in Egypt

Coagulopathy Clinical Trial

Official title:
Assessment of COVID-19 Associated Coagulopathy and Hypercoagulable State in Upper Egypt

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04507230
Other study ID # 17300413
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 7, 2020
Est. completion date October 31, 2020

Study information
Verified date March 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy in patients hospitalized with COVID-19 (COVID-19-associated coagulopathy) is characterized by increased D-dimer and fibrinogen levels. 71% of patients who did not survive hospitalization reported to have developed disseminated intravascular coagulation (DIC) compared to 0.6% of survivors.

Description:

studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors.

Recruitment information / eligibility
Status Completed
Enrollment 106
Est. completion date October 31, 2020
Est. primary completion date October 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - patients with COVID 19 positive by RT- PCR Exclusion Criteria: - no exclusions

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Egypt Assiut University Hospitals Assiut

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Coagulation screen Full coagulation screen 1 month
Primary Thrombophilia screen Full thrombophilia screen 1 month
Primary VWF, FVIII VWFAg, FVIII 1 month
See also
  Status Clinical Trial Phase
Recruiting NCT01912547 - Thromboelastography During Surgery for Malignant Pleural Mesothelioma Phase 0
Completed NCT03674684 - ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation
Recruiting NCT05874843 - Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients N/A
Withdrawn NCT04705701 - Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care N/A
Not yet recruiting NCT04515420 - The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
Completed NCT01598831 - Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy Phase 3
Completed NCT04580563 - Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study N/A
Withdrawn NCT04274699 - Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Terminated NCT02540434 - Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions N/A
Completed NCT02203968 - Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) Phase 1/Phase 2
Unknown status NCT01854476 - Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze Phase 2/Phase 3
Completed NCT00816127 - Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction N/A
Active, not recruiting NCT02926274 - Transfusion Using Stored Whole Blood N/A
Completed NCT05295693 - Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Not yet recruiting NCT04582188 - The Early Coagulopathy for the Prognosis in Sepsis
Recruiting NCT04528888 - Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection Phase 3
Recruiting NCT05449834 - Fibrinogen Early In Severe Trauma StudY II Phase 3
Withdrawn NCT04435015 - The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications Phase 1/Phase 2
Not yet recruiting NCT04115722 - Coagulation Parameters in IBD Patients
Completed NCT01228058 - A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients N/A

External Links